Clinical Trials in Vermont (VT) | Vermont Clinical Drug Trials & Studies

You are viewing Clinical Trials In Vermont

Have multiple conditions? Click here

Showing 1-100 of 338

There are 338 trials in Vermont

Name	City	State	Zip
PEAK: A Phase 2 Study of Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer Subjects With Wild-Type KRAS Tumors	White River Junction	VT
Efficacy and Safety of Daclizumab High Yield Process Versus Interferon Î² 1a in Patients With Relapsing-Remitting Multiple Sclerosis	White River Junction	VT
A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD)	White River Junction	VT
A Phase 2 Study of BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus Infection	White River Junction	VT
Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate Therapy	White River Junction	VT	05009
Strategic Timing of Antiretroviral Treatment	White River Junction	VT	05009
ActiveStep Comparative Effectiveness Trial	White River Junction	VT	05009
INSIGHT H1N1v Hospitalization Study (FLU 003)	White River Junction	VT	05009
INSIGHT H1N1v Outpatient Study (FLU 002)	White River Junction	VT	05009
Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer	St Johnsbury	VT	05819
Single-Fraction Compared With Multiple-Fraction Therapy in Treating Patients With Previously Irradiated Painful Bone Metastases	St Johnsbury	VT	05819
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer	St Johnsbury	VT	05819
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer	St Johnsbury	VT	05819
Radiation Therapy and Cisplatin in Treating Patients With Stage I Bladder Cancer	St Johnsbury	VT	05819
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery	St Johnsbury	VT	05819
Using Telephone Technology to Prevent Relapse After Alcoholism Treatment	South Burlington	VT	05403
A Telephone Feedback System for Prevention of Chronic Pain Relapse	South Burlington	VT	05403
Welchol as Monotherapy for Type 2 Diabetes Mellitus	South Burlington	VT	05403
Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing	South Burlington	VT	05403
An Open-Label Study of Trastuzumab-MCC-DM1 (T-DM1) vs. Capecitabine + Lapatinib in Patients With HER2-Positive Locally Advanced or Metastatic Breast Cancer	South Burlington	VT	05403
A Study to Evaluate the Efficacy, Response Duration and Safety of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine Treatment (H1)	South Burlington	VT	05403
A Study of the Efficacy and Safety of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine Treatment (H1)	South Burlington	VT	05403
A Study of the Safety and Pharmacokinetics of Escalating Doses of DSTP3086S in Patients With Metastatic Castration-Resistant Prostate Cancer	South Burlington	VT	05403
A Safety Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic Despite Treatment With H1 Antihistamines, H2 Blockers, and/or Leukotriene Receptor Antagonists	South Burlington	VT	05403
A Study to Evaluate Corrected QT Interval and Drug-Drug Interaction of Trastuzumab on Carboplatin in the Presence of Docetaxel in Patients With HER2-Positive Metastatic or Locally Advanced Inoperable Cancer	South Burlington	VT	05403
Safety of QMF149 TwisthalerÂ® in Adolescent and Adult Patients With Asthma	South Burlington	VT	05403
Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes	South Burlington	VT	05403
Safety and Efficacy of N8 in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543 and NN7008-3545	South Burlington	VT	05403
A Study of ABT-263 in Combination With Dose-Intensive Rituximab, or Dose-Intensive Rituximab Alone, in Previously Untreated Patients With B-Cell, Chronic Lymphocytic Leukemia (CLL)	South Burlington	VT	05403
Extension to QTI571A2301 to Evaluate the Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension	South Burlington	VT	05403
A Study of the Safety and Pharmacokinetics of MFGR1877S in Patients With Relapsed or Refractory t(4;14)-Positive Multiple Myeloma	South Burlington	VT	05403
Safety and Efficacy of Recombinant Factor VIII (N8) in Previously Treated Male Children With Haemophilia A	South Burlington	VT	05403
Efficacy and Safety Study of a Single Injection of SCH 900962 Versus Daily recFSH Injections in Women Undergoing Controlled Ovarian Stimulation (Study P06029)	South Burlington	VT	05403
Frozen-thawed Embryo Transfer (FTET) Cycle Follow-up Protocol (Study P06031)	South Burlington	VT	05403
A Study of the Effects of Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA)	South Burlington	VT	05403
Clinical Trial Evaluating the Efficacy and Safety of TechnosphereÂ® Inhalation Insulin (TI) Inhalation Powder Using the Gen2 Inhaler	South Burlington	VT	05403
Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia A	South Burlington	VT	05403
A Study of Growth in Patients Using the Nutropin AQ Nuspin	South Burlington	VT	05403
Efficacy, Safety, and Pharmacokinetics of QAW039	South Burlington	VT	05403
A Study to Evaluate the Safety, Tolerability, and Activity of Intravenous MLDL1278A in Patients on Standard-of-Care Therapy for Stable Atherosclerotic Cardiovascular Disease	South Burlington	VT	05403
Safety of QMF149 TwisthalerÂ® in Adolescent and Adult Patients With Asthma	South Burlington	VT	05403
A Safety Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic Despite Treatment With H1 Antihistamines, H2 Blockers, and/or Leukotriene Receptor Antagonists	South Burlington	VT	05403
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results - A Long Term Evaluation	South Burlington	VT	05403
Clinical Trial Evaluating the Efficacy and Safety of TechnosphereÂ® Inhalation Insulin (TI) Inhalation Powder Using the Gen2 Inhaler	South Burlington	VT	05403
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma	South Burlington	VT
A Study of the Bronchodilator Effect of Formoterol Fumarate Used in Combination With Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P06476)	South Burlington	VT	05403
Single-Fraction Compared With Multiple-Fraction Therapy in Treating Patients With Previously Irradiated Painful Bone Metastases	Rutland	VT	05701
Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer	Rutland	VT	05701
Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer	Rutland	VT	05701
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer	Rutland	VT	05701
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma	Rutland	VT	05701
Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC	Rutland	VT
Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics (Glitz Asthma)	Colchester	VT	05446
Evaluation of Loratadine for Prevention of Pegfilgrastim-Induced Pain	Colchester	VT	05446
Neoadjuvant Cisplatin/Docetaxel (CDDP/TXT) and Chemoradiation for Head and Neck Cancer	Colchester	VT	05446
A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF)	Colchester	VT	05446
Compassionate Use of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES)	Burlington	VT	05401
A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)	Burlington	VT	05401
Safety and Efficacy Study of Adding GSK2190915 to Low Dose Inhaled Corticosteroid Treatment for Asthma	Burlington	VT	05401
System Longevity Study: Evaluating Reliability and Performance of Medtronic Cardiac Therapy Products	Burlington	VT
Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Pulmonary Embolism With Or Without Symptomatic Deep-Vein Thrombosis: Einstein-PE Evaluation	Burlington	VT
Juvenile Idiopathic Arthritis (JIA) Registry	Burlington	VT
A Study to Evaluate the Safety and Effectiveness of CNTO 888 Administered Intravenously (IV) in Subjects With Idiopathic Pulmonary Fibrosis (IPF)	Burlington	VT
Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC	Burlington	VT
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)	Burlington	VT
Model 4195 Left Ventricular (LV) Lead Chronic Performance Study	Burlington	VT
A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic DMARDs	Burlington	VT
A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One TNF-Inhibitor	Burlington	VT
Study Comparing 3 Dosage Levels of SAM-531 in Outpatients With Mild to Moderate Alzheimer Disease.	Burlington	VT
A Study to Evaluate the Safety and Effectiveness of Ustekinumab or Golimumab Administered Subcutaneously (SC) in Patients With Sarcoidosis	Burlington	VT
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome	Burlington	VT
Adaptive Cardiac Resynchronization Therapy Study	Burlington	VT
Feasibility Study of an Integrated Diagnostic System to Manage Heart Failure	Burlington	VT
4965 Post-approval Study	Burlington	VT
4968 Post-approval Study	Burlington	VT
nEw3 Post-approval Study	Burlington	VT
Safety and Efficacy of Lu AA21004 in Adults With Major Depressive Disorder	Burlington	VT
Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue Sarcoma	Burlington	VT
MP-376 (Aeroquinâ„¢, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis	Burlington	VT
A 58-Week Safety and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-stage Renal Disease (ESRD) on Dialysis	Burlington	VT
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer	Burlington	VT
Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects	Burlington	VT
Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer	Burlington	VT	05401
Follow-Up Study for Exubera	Burlington	VT	05401
Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer	Burlington	VT	05401
Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease	Burlington	VT	05401
Study Evaluating The Long-Term Safety And Efficacy Of Subcutaneous Bapineuzumab	Burlington	VT	05401
A Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's Disease	Burlington	VT	05401
Dynamic Aspects of Amino Acid Metabolism	Burlington	VT	05401
Estrogen Modulation of Mood and Cognition Following Monoaminergic Depletion in Post-Menopausal Women	Burlington	VT	05401
Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma	Burlington	VT	05401
Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma	Burlington	VT	05401
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors	Burlington	VT	05401
Generic Database of Very Low Birth Weight Infants	Burlington	VT	05401
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer	Burlington	VT	05401
Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma	Burlington	VT	05401
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma	Burlington	VT	05401
Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases	Burlington	VT	05401
Study of Late-Occurring Complications in Childhood Cancer Survivors	Burlington	VT	05401
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma	Burlington	VT	05401

View Clinical Trial Facilities in Vermont

Showing 1-100 of 338